Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company has concluded an agreement with Chinese partners to build a new plant. The enterprise will specialize in the production of pharmaceutical substances that are necessary for creating finished medicinal products.
The project will be implemented in the Irkutsk region. The total investment cost for construction is estimated at 13.06 billion tenge. The parties have already agreed on the distribution of tasks and the commencement of preparatory work at the site.
Establishing domestic production of substances is an important step for Russian medicine. This will help reduce dependence on imported components and provide domestic pharmacies and hospitals with necessary medications. The use of Chinese technologies will help accelerate the process of launching new production lines.
It is expected that the plant will begin operations in the coming years. The implementation of this project will strengthen economic cooperation between Russia and China in the healthcare sector and help the development of the pharmaceutical industry in the Siberian region.